Well it’s an unusual situation.
Your statement about the obvious effectiveness is a little premature.
As for the trials. There will be many people aware of the accuracy of the technology during the trial: especially all the doctors involved. While they only have anecdotal observations and not overall sensitivity and specificity they will have a view and could buy or sell accordingly
Well it’s an unusual situation. Your statement about the obvious...
-
- There are more pages in this discussion • 245 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EMV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.14 |
Change
0.120(5.94%) |
Mkt cap ! $175.3M | |||
| Open | High | Low | Value | Volume |
| $2.05 | $2.14 | $2.05 | $80.72K | 39.02K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1535 | $2.05 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.14 | 857 | 1 |
View Market Depth
| Last trade - 15.57pm 13/09/2024 (20 minute delay) ? |
| EMV (ASX) Chart |